Møller N - Search Results

1

Effect of tighter glycemic control on cardiac function, exercise capacity, and muscle strength in heart failure patients with type 2 diabetes: a randomized study.

Nielsen R, Wiggers H, Thomsen HH, Bovin A, Refsgaard J, Abrahamsen J, Møller N, Bøtker HE, Nørrelund H. Nielsen R, et al. Among authors: moller n. BMJ Open Diabetes Res Care. 2016 Apr 29;4(1):e000202. doi: 10.1136/bmjdrc-2016-000202. eCollection 2016. BMJ Open Diabetes Res Care. 2016. PMID: 27158520 Free PMC article.

2

Insulin resistance in microvascular angina (syndrome X).

Bøtker HE, Møller N, Ovesen P, Mengel A, Schmitz O, Orskov H, Bagger JP. Bøtker HE, et al. Among authors: moller n. Lancet. 1993 Jul 17;342(8864):136-40. doi: 10.1016/0140-6736(93)91344-l. Lancet. 1993. PMID: 8101255

3

Insulin resistance in cardiac syndrome X and variant angina: influence of physical capacity and circulating lipids.

Bøtker HE, Frøbert O, Møller N, Christiansen E, Schmitz O, Bagger JP. Bøtker HE, et al. Among authors: moller n. Am Heart J. 1997 Aug;134(2 Pt 1):229-37. doi: 10.1016/s0002-8703(97)70129-7. Am Heart J. 1997. PMID: 9313602

4

Myocardial insulin resistance in patients with syndrome X.

Botker HE, Moller N, Schmitz O, Bagger JP, Nielsen TT. Botker HE, et al. Among authors: moller n. J Clin Invest. 1997 Oct 15;100(8):1919-27. doi: 10.1172/JCI119722. J Clin Invest. 1997. PMID: 9329954 Free PMC article.

5

Serum leptin concentrations during short-term administration of growth hormone and triiodothyronine in healthy adults: a randomised, double-blind placebo-controlled study.

Wolthers T, Lechuga A, Grøfte T, Nørrelund H, Møller N, Christiansen JS, Jørgensen JO. Wolthers T, et al. Among authors: moller n. Horm Metab Res. 1999 Jan;31(1):37-40. doi: 10.1055/s-2007-978694. Horm Metab Res. 1999. PMID: 10077348 Clinical Trial.

6

Muscle mass and function in thyrotoxic patients before and during medical treatment.

Nørrelund H, Hove KY, Brems-Dalgaard E, Jurik AG, Nielsen LP, Nielsen S, Jørgensen JO, Weeke J, Møller N. Nørrelund H, et al. Among authors: moller n. Clin Endocrinol (Oxf). 1999 Dec;51(6):693-9. doi: 10.1046/j.1365-2265.1999.00861.x. Clin Endocrinol (Oxf). 1999. PMID: 10619973

7

Effects of growth hormone administration on protein dynamics and substrate metabolism during 4 weeks of dietary restriction in obese women.

Nørrelund H, Børglum J, Jørgensen JO, Richelsen B, Møller N, Nair KS, Christiansen JS. Nørrelund H, et al. Among authors: moller n. Clin Endocrinol (Oxf). 2000 Mar;52(3):305-12. doi: 10.1046/j.1365-2265.2000.00937.x. Clin Endocrinol (Oxf). 2000. PMID: 10718828 Clinical Trial.

8

Continuation of growth hormone (GH) therapy in GH-deficient patients during transition from childhood to adulthood: impact on insulin sensitivity and substrate metabolism.

Nørrelund H, Vahl N, Juul A, Møller N, Alberti KG, Skakkebaek NE, Christiansen JS, Jørgensen JO. Nørrelund H, et al. Among authors: moller n. J Clin Endocrinol Metab. 2000 May;85(5):1912-7. doi: 10.1210/jcem.85.5.6613. J Clin Endocrinol Metab. 2000. PMID: 10843174 Clinical Trial.

9

Muscle mass and function in thyrotoxic patients before and during medical treatment.

Norrelund H, Moller N. Norrelund H, et al. Among authors: moller n. Clin Endocrinol (Oxf). 2000 Oct;53(4):541. doi: 10.1046/j.1365-2265.2000.1110a.x. Clin Endocrinol (Oxf). 2000. PMID: 11012584 No abstract available.

10

The protein-retaining effects of growth hormone during fasting involve inhibition of muscle-protein breakdown.

Nørrelund H, Nair KS, Jørgensen JO, Christiansen JS, Møller N. Nørrelund H, et al. Among authors: moller n. Diabetes. 2001 Jan;50(1):96-104. doi: 10.2337/diabetes.50.1.96. Diabetes. 2001. PMID: 11147801

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

685 results

Search Page

Filters